![John Mark Lucas](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
John Mark Lucas is the founder of Axelyf, Inc. Former jobs include Chief Executive Officer at Cizzle Biotechnology Ltd., Chief Executive Officer & Executive Director at Oxford Cannabinoid Technologies Holdings Plc from 2021 to 2022, Director of New Product Development & IP at Venture Life Group Plc, Vice President-World Wide Intellectual Property at Serono Genetics Institute SA, Vice President-Intellectual Property at Metabasis Therapeutics, Inc., General Counsel at Silence Therapeutics Plc from 2009 to 2010, Vice President-Intellectual Property at TransForm Pharmaceuticals, Inc., Vice President-Worldwide Intellectual Property at Genset Corp., Head-Patents at Boehringer Ingelheim Pharma GmbH & Co., KG, and Vice President-Intellectual Property at Ilika Plc.
Education includes a graduate degree from George Washington University, a doctorate from The Ohio State University, and undergraduate and graduate degrees from The Ohio University.
| Companies | Position | Start |
|---|
| Companies | Position | End |
|---|---|---|
| OXFORD CANNABINOID TECHNOLOGIES HOLDINGS PLC | Chief Executive Officer | 2022-12-01 |
| VENTURE LIFE GROUP PLC | Director/Board Member | 2014-08-04 |
| ILIKA PLC | Corporate Officer/Principal | - |
Boehringer Ingelheim Pharma GmbH & Co., KG
 Boehringer Ingelheim Pharma GmbH & Co., KG BiotechnologyHealth Technology Operates research-based pharmaceutical companies and serves | Corporate Officer/Principal | - |
Genset Corp.
 Genset Corp. Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceuticals | Corporate Officer/Principal | - |
Active
Inactive
Listed companies
Private companies
| Private companies | 13 |
|---|---|
Serono Genetics Institute SA
 Serono Genetics Institute SA Miscellaneous Commercial ServicesCommercial Services Operates a biotechnology company specializing in synthetic DNA and genetic analysis | Commercial Services |
Metabasis Therapeutics, Inc.
 Metabasis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops small molecule drugs | Health Technology |
Silence Therapeutics Plc
 Silence Therapeutics Plc Miscellaneous Commercial ServicesCommercial Services Engages in the research and development of novel pharmaceutical products | Commercial Services |
George Washington University
 George Washington University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Ohio State University
 The Ohio State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Ohio University
 The Ohio University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
TransForm Pharmaceuticals, Inc.
 TransForm Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs | Health Technology |
Genset Corp.
Genset Corp. Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceuticals | Health Technology |
Cizzle Biotechnology Ltd.
 Cizzle Biotechnology Ltd. BiotechnologyHealth Technology Develops therapeutic products for lung cancer | Health Technology |
Boehringer Ingelheim Pharma GmbH & Co., KG
Boehringer Ingelheim Pharma GmbH & Co., KG BiotechnologyHealth Technology Operates research-based pharmaceutical companies and serves | Health Technology |
Ilika Plc
 Ilika Plc Electrical ProductsProducer Manufacturing Manufactures solid state batteries | Producer Manufacturing |
Venture Life Group Plc
 Venture Life Group Plc Pharmaceuticals: MajorHealth Technology Manufactures and markets consumer healthcare & cosmetics products | Health Technology |
Oxford Cannabinoid Technologies Holdings Plc
 Oxford Cannabinoid Technologies Holdings Plc Pharmaceuticals: MajorHealth Technology Provides cannabinoid drug development services | Health Technology |
Select your edition
All financial news and data tailored to specific country editions
